跳转至内容
Merck
CN

SML4230

Cannabigerol

≥98% (HPLC), powder, CB1R and CB2R receptor agonist

别名:

2-[(2E)-3,7-dimethyl-2,6-octadien-1-yl]-5-pentyl-1,3-benzenediol, 2-((2E)-3,7-Dimethylocta-2,6-dienyl)-5-pentylbenzene-1,3-diol, CBG

登录 查看组织和合同定价。

选择规格

变更视图

关于此项目

经验公式(希尔记法):
C21H32O2
化学文摘社编号:
分子量:
316.48
MDL number:
NACRES:
NA.21
Assay:
≥98% (HPLC)
Form:
powder
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


Quality Segment

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

SMILES string

OC1=C(C(O)=CC(CCCCC)=C1)C/C=C(C)/CCC=C(C)C

Application

Cannabigerol may be used to study its binding properties to cannabinoid CB1 (CB1R) and CB2 (CB2R) receptors and its effects on agonist activation of those receptors and of CB1–CB2 heteroreceptor complexes.

Biochem/physiol Actions

Cannabigerol is a non-psychoactive phytocannabinoid. Cannabigerol binds CB1 and CB2 receptors with Ki values of 440 and 337 nM, respectively and acts as a partial agonist against CB1 and CB2 receptor subtypes. The compound is a potent a2-adrenoceptor agonist (EC50 = 0.2 nM). Cannabigerol modulates the expression of proinflammatory proteins, such as TNF-α, IL-1β, IL-6, IL-10, interferon-γ, and prostaglandin E2. CBG displays a broad spectrum of biological activities, including anti-inflammatory, antibacterial, and antifungal effects, as well as the regulation of redox balance and neuromodulatory properties.


Still not finding the right product?

Explore all of our products under Cannabigerol


pictograms

Health hazardExclamation mark

signalword

Warning

Hazard Classifications

Acute Tox. 4 Oral - Repr. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库